Le Lézard
Classified in: Health
Subjects: POL, AVO

Canada's pharmacists call for full population drug coverage, enhanced care


It's time for a pan-Canadian 'PharmAccord' that will deliver universal drug coverage for Canadians, ensure access to medications

OTTAWA, Dec. 6, 2017 /CNW/ - Today, the Canadian Pharmacists Association (CPhA) presented a plan that will allow governments to provide universal drug coverage to all Canadians, ensure comprehensive access to medications in Canada and leverage pharmacist care to better utilize medications and improve patient outcomes.

CPhA logo bilingual (CNW Group/Canadian Pharmacists Association)

"As pharmacists, we strive to ensure that every patient that walks through our door will have access to the drugs that they need, when they need it," says Alistair Bursey, Chair, CPhA. "However, 10-15 per cent of Canadians currently have either no insurance or insufficient insurance to afford their medications. This is unacceptable in a country as prosperous as Canada."

"Forcing Canadians to choose between paying for their prescriptions and hydro is not the Canadian way," added Bursey. "We need to build on the success of existing drug plans to provide Canadians with complete coverage in a manner that is affordable to government."

The federal government recently agreed to a health accord that provides investments for provinces and territories to improve health outcomes for Canadians in specific areas. Pharmacists believe the next accord should provide federal investments to support better drug coverage for Canadians while recognizing the unique needs of Canadians in every province and territory.

This is why Canada's pharmacists are calling on governments to commit to a PharmAccord that would:

"Cost should never be a factor for a Canadian seeking a life-saving drug therapy," says Perry Eisenschmid, CPhA CEO. "Leveraging the knowledge and experience of Canada's pharmacists, Canadians can have access to universal drug coverage by government adoption and implementation of a five-pillar PharmAccord."

Further Information: Rx: PharmAccord ? A Prescription for a Healthier Canada

iPoliticsLive Event

A panel discussion, hosted by iPolitics, was held today following remarks by the Canadian Pharmacists and included: John Oliver MP (Oakville) ? Member of the Standing Committee on Health; Janet Yale ? President and CEO Arthritis Society (Canada); Iris Krawchenko ? Senior Pharmacist Advisor at Canadian Pharmacists Association; and Mostafa Askari ? Deputy Parliamentary Budget Officer. Susan Delacourt, Columnist at the Toronto Star, moderated. 

About the Canadian Pharmacists Association

The Canadian Pharmacists Association (CPhA) is the uniting national voice of pharmacy and the pharmacist profession in Canada. As pharmacists undertake an enhanced role in the delivery of health care services, CPhA ensures that the profession is recognized as a national leader in health care, influencing the policies, programs, budgets and initiatives affecting the profession and the health of Canadians. More information is available at www.pharmacists.ca.

 

SOURCE Canadian Pharmacists Association


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: